Image Library

Cover Image
Volume 221: Binding & modification of LDL to the extracellular matrix as part of the proatherogenic inflammatory cascade. Didangelos et al 2012


Cover Image
Volume 220: Mechanisms of action of ApoA-V: (A) in plasma & (B) in the liver. Nilsson et al, Atherosclerosis November 2011


Cover Image
Volume 219: Mechanisms of action of ApoA-V: (A) in plasma & (B) in the liver. Nilsson et al, Atherosclerosis November 2011


Cover Image
Volume 218: (A) Impact of ω-3 PUFAs on coronary plaque instability: An integrated backscatter intravascular ultrasound study; (B) Lower serum ω-3 PUFAs associated with lipid-rich plaques, suggests contribution to incidence of acute coronary syndrome. Amano et al, Atherosclerosis 2011


Cover Image
Volume 217: Antibody targeting interleukin 1ß hampers atherosclerosis progression in apoE–/– mice Andrea Cignarella Atherosclerosis 2011


Cover Image
Volume 216: Loss of a disulfide bond in LCAT resulting in proteinurea in early childhood. Holleboom et al, Atherosclerosis 2011.


Cover Image
Volume 215: Thermal mapping of the abdominal aorta of rabbits using microwave radiometry. Toutouzas et al, Atherosclerosis 2011.


Cover Image
Volume 214: Perivascular adipose tissue & its possible involvement in atherogenesis. Paracrine effects of cytokines & adipokines may be exerted on (1) endothelium (2) adjacent tissues. Verhagen & Visseren 2011.


Cover Image
Volume 213: Aortic atherosclerosis in rabbits with High-Fat diet (HFD) without excess calories. Waqar et al 2010.


Cover Image
Volume 212: Optical molecular imaging approach to quantify matrix metalloproteinase activity within the walls of AAAs in a rodent model.


Cover Image
Volume 211: Calcium phosphate ridge indicating LPC induces osteogenic morphology, physiology, gene expression & phenotype in vascular smooth muscle cells. Vickers et al 2010.


Cover Image
Volume 210: Regulation of arginase pathway in response to wall shear stress.


Cover Image
Volume 209: mMRI: Ligand-conjugated microparticles of iron oxide bind to upregulated molecular targets on the vascular endothelium in atherosclerosis and vascular infl ammation.


Cover Image
Volume 208: Elagitannins from pomegranate juice activate PON-1 secretion from hepatocytes in a process involving PPARγ thus inhibiting LDL & HDL oxidation.